Faktor Risiko Infeksi Citomegalovirus Pada Anak Yang Dicurigai Kurang Pendengaran
DOI:
https://doi.org/10.36408/mhjcm.v7i1.428Keywords:
Infeksi CMV, Faktor risiko, Kurang pendengaranAbstract
Latar belakang : Infeksi Citomegalovirus (CMV) merupakan infeksi kongenital tersering pada bayi dan anak, 1 – 6% bayi lahir hidup. Infeksi CMV menimbulkan kecacatan permanen, salah satunya kurang pendengaran.
Tujuan: Mengetahui faktor risiko infeksi CMV pada anak yang dicurigai kurang pendengaran.
Metode: Penelitian cross sectional di Clinic Diagnostic RSUP Dr Kariadi Semarang periode Januari-Maret 2019. Sampel ditentukan sebanyak 97 anak dengan kecurigaan kurang pendengaran, yang memenuhi kriteria inklusi, ekslusi. Diagnosis dan derajat kurang pendengaran berdasar pemeriksaan Brainstem Evoked Response Audiometry, Otoacustic Emission dan timpanometri. Infeksi CMV ditentukan dengan pemeriksaan laboratorium. Analisis data menggunakan uji Chi- square.
Hasil: Didapatkan 56 (57,7%) anak kurang dengar, kurang pendengaran derajat berat-sangat berat didapatkan pada 48 (85,71%) anak. Infeksi CMV didapatkan pada 59 (60,8%) anak dengan kadar IgG CMV diatas 25UI/ml sebanyak 43(72,88%) anak. Infeksi CMV merupakan faktor resiko kurang pendengaran (p<0,001 RP 16,364 IK 95% 5,9-45,31). Infeksi CMV tidak berpengaruh pada jumlah telinga yang terganggu (p=0,470) dan umur saat dilakukan pemeriksaan BERA (p=0,428). Kadar IgG CMV berpengaruh terhadap kurang pendengaran (p<0,001), namun tidak berpengaruh pada derajat kurang pendengaran (p=0,370) dan umur saat dilakukan pemeriksaan BERA (p=0,516) dengan kadar IgG CMV.
Simpulan: Infeksi CMV merupakan faktor resiko kurang pendengaran pada anak yang dicurigai kurang dengar. Kadar IgG CMV berpengaruh terhadap kurang pendengaran.
Kata kunci : Infeksi CMV, Faktor risiko, Kurang pendengaran
Background : Citomegalovirus (CMV) infection is the most common congenital infection, 1 - 6% born alive infant. CMV infection causes permanent disability, one of which is hearing loss.
Objective: To determine CMV infection risk factors in suspected hearing loss children.
Method: Cross-sectional study at the Clinic Diagnostic Centre of Dr. Kariadi Hospital Semarang, January-March 2019. Samples were determined as 97 children with suspicion of hearing loss, fulfill inclusion and exclusion criteria. Diagnosis and severity of hearing impairment are based on an examination of Brainstem Evoked Response Audiometry (BERA), Otoacustic Emission (OAE) and Tympanometry. CMV infection is determined by laboratory examination. Data analysis using Chi-square test.
Results: Obtained 56 (57.7%) children with hearing loss, 48 (85.71%) children with severe-profound hearing loss. CMV infection was found in 59 (60.8%) children, IgG CMV titers above 25UI / ml found in 43 (72.88%) children. CMV infection is a risk factor for hearing loss (p<0.001 RP 16.364 95% CI 5.9-45.31). CMV infection had no effect on laterality of hearing loss (p=0.470) and age at the BERA examination performed (p=0.428). IgG CMV titers had an effect on hearing loss (p <0.001), but had no effect on severity of hearing loss (p = 0.370) and age at the BERA examination performed (p = 0.516).
Conclusion: CMV infection is a hearing loss risk factor in suspected of hearing loss children. IgG CMV titers affect hearing loss.
Keywords: CMV infection, risk factor, hearing loss
Downloads
References
2. Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972-82.
3. Identifying Congenital Cytomegalovirus (CMV) Early in Life: Information for Healthcare Provider. 2017; 35:45-5.
4. Augustine AM, Jana AK, Kuruvilla KA, Danda S, Lepcha A, Ebenezer J, et al. Neonatal hearing screening—Experience from a tertiary care hospital in Southern India. Indian pediatrics. 2014;51(3):179-83.
5. Pratama BF. Infeksi Cytomegalovirus kongenital. Jurnal Kesehatan Melayu. 2018;1(2):114-7.
6. Palma S, Roversi MF, Bettini M, Mazzoni S, Pietrosemoli P, Lucaccioni L, et al. Hearing loss in children with congenital cytomegalovirus infection: an 11-year retrospective study based on laboratory database of a tertiary paediatric hospital. Acta otorhinolaryngologica italica 2019;39:40-5.
7. Dumanch KA, Holte L, O’Hollearn T, Walker E, Clark J, Oleson J. High risk factors associated with early childhood hearing loss: a 3-year review. American journal of audiology.2017: 1-14.
8. Halwachs-Baumann G. Congenital Cytomegalovirus Infection and Hearing Impairment. Clin Res. 2016;3(2):1029
9. Dobbie AM. Evaluation and management of cytomegalo virus associated congenital hearing loss. Curr Opin Otolaryngol Head Neck Surg.2017;25:390–5.
10. Furutate S, Iwasaki S, Nishio S, Moteki H, Usami S. Clinical profile of hearing loss in children with congenital cytomegalovirus (CMV) infection: CMV DNA diagnosis using preserved umbilical cord. Acta Oto-Laryngologica, 2011; 131: 976–982.
11. Rampengan NH. Diagnosis infeksi sitomegalovirus pada bayi dan anak. Jurnal Biomedik.2015;7(3):137-43.
12. Misono S, Sie KC., Weiss NS., Huang M, Boeckh, Norton SJ, et al. Congenital cytomegalovirus infection in pediatric hearing loss. Arch Otolaryngol Head Neck Surg. 2011;137(1):47-53.
13. Adler SP, Marshall B. Cytomegalovirus Infections. Pediatrics in Review.2007;28 (3): 92-100.
14. Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen K E, Woodruff JL, et al. A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics. 2017;139 (2):1-7.
15. Lanzieri TM, Chung W, Flores M, Blum P, Caviness AC, Bialek SR, et al. Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection. Pediatrics. 2017;138(1):57-65.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2020 Medica Hospitalia : Journal of Clinical Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.